Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders

被引:10
|
作者
Fridkis-Hareli, Masha [1 ]
机构
[1] ATR LLC, Worcester, MA 01606 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2013年
关键词
AMINO-ACID COPOLYMERS; MYELIN BASIC-PROTEIN; T-CELL RESPONSES; REMITTING MULTIPLE-SCLEROSIS; ANTIGEN-PRESENTING CELLS; HISTOCOMPATIBILITY COMPLEX-MOLECULES; HLA-DR MOLECULES; RHEUMATOID-ARTHRITIS; GLATIRAMER ACETATE; EXPERIMENTAL ENCEPHALOMYELITIS;
D O I
10.1155/2013/826191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune disorders, that occur when autoreactive immune cells are induced to activate their responses against self-tissues, affect one percent of the world population and represent one of the top 10 leading causes of death. The major histocompatibility complex (MHC) is a principal susceptibility locus for many human autoimmune diseases, in which self-tissue antigens providing targets for pathogenic lymphocytes are bound to HLA molecules encoded by disease-associated alleles. In spite of the attempts to design strategies for inhibition of antigen presentation targeting the MHC-peptide/TCR complex via generation of blocking antibodies, altered peptide ligands (APL), or inhibitors of costimulatory molecules, potent therapies with minimal side effects have yet to be developed. Copaxone (glatiramer acetate, GA) is a random synthetic amino acid copolymer that reduces the relapse rate by about 30% in relapsing-remitting multiple sclerosis (MS) patients. Based on the elucidated binding motifs of Copaxone and of the anchor residues of the immunogenic myelin basic protein (MBP) peptide to HLA-DR molecules, novel copolymers have been designed and proved to be more effective in suppressing MS-like disease in mice. In this report, we describe the rationale for design of second-generation synthetic random copolymers as candidate drugs for a number of MHC class-II-associated autoimmune disorders.
引用
收藏
页数:9
相关论文
共 37 条
  • [1] Endothelial expression of MHC class II molecules in autoimmune disease
    Turesson, C
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (02) : 129 - 143
  • [2] In Vivo Enhancement of Peptide Display by MHC Class II Molecules with Small Molecule Catalysts of Peptide Exchange
    Call, Melissa J.
    Xing, Xuechao
    Cuny, Gregory D.
    Seth, Nilufer P.
    Altmann, Daniel M.
    Fugger, Lars
    Krogsgaard, Michelle
    Stein, Ross L.
    Wucherpfennig, Kai W.
    JOURNAL OF IMMUNOLOGY, 2009, 182 (10) : 6342 - 6352
  • [3] Enhancing tumor vaccines: catalyzing MHC class II peptide exchange
    Croft, Nathan P.
    Purcell, Anthony W.
    EXPERT REVIEW OF VACCINES, 2010, 9 (02) : 129 - 132
  • [4] HLA CLASS-II-ASSOCIATED GENETIC SUSCEPTIBILITY IN MULTIPLE-SCLEROSIS - A CRITICAL-EVALUATION
    OLERUP, O
    HILLERT, J
    TISSUE ANTIGENS, 1991, 38 (01): : 1 - 15
  • [5] Citrullination only infrequently impacts peptide binding to HLA class II MHC
    Sidney, John
    Becart, Stephane
    Zhou, Mimi
    Duffy, Karen
    Lindvall, Mikaela
    Moore, Erin C.
    Moore, Eugene L.
    Rao, Tadimeti
    Rao, Navin
    Nielsen, Morten
    Peters, Bjoern
    Sette, Alessandro
    PLOS ONE, 2017, 12 (05):
  • [6] High-throughput engineering and analysis of peptide binding to class II MHC
    Jiang, Wei
    Boder, Eric T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (30) : 13258 - 13263
  • [7] Unnatural amino acids improve affinity and modulate immunogenicity: Developing peptides to treat MHC type II autoimmune disorders
    Meister, Daniel
    Taimoory, S. Maryamdokht
    Trant, John F.
    PEPTIDE SCIENCE, 2019, 111 (01)
  • [8] MHC class II complexes sample intermediate states along the peptide exchange pathway
    Wieczorek, Marek
    Sticht, Jana
    Stolzenberg, Sebastian
    Guenther, Sebastian
    Wehmeyer, Christoph
    El Habre, Zeina
    Alvaro-Benito, Miguel
    Noe, Frank
    Freund, Christian
    NATURE COMMUNICATIONS, 2016, 7
  • [9] Methyldopa blocks MHC class II binding to disease-specific antigens in autoimmune diabetes
    Ostrov, David A.
    Alkanani, Aimon
    McDaniel, Kristen A.
    Case, Stephanie
    Baschal, Erin E.
    Pyle, Laura
    Ellis, Sam
    Pollinger, Bernadette
    Seidl, Katherine J.
    Shah, Viral N.
    Garg, Satish K.
    Atkinson, Mark A.
    Gottlieb, Peter A.
    Michels, Aaron W.
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (05) : 1888 - 1902
  • [10] HLA-DMA Polymorphisms Differentially Affect MHC Class II Peptide Loading
    Alvaro-Benito, Miguel
    Wieczorek, Marek
    Sticht, Jana
    Kipar, Claudia
    Freund, Christian
    JOURNAL OF IMMUNOLOGY, 2015, 194 (02) : 803 - 816